The insertion of specific cell function-altering genetic material into a patient to treat a genetic condition is known as gene therapy. The efficient delivery of genes to the target tissue/cells, which is carried out using gene delivery vehicles known as vectors, is a critical step in gene therapy. Viruses and non-viral vectors are the two types of vectors. The use of viruses for therapeutic purposes has long been done, and virotherapies are a family of viral-based treatments. Perhaps a lack of complete understanding of viral biology was the fundamental reason why prior viral-based medicines failed to attain efficacy. With 40 years of virus research, there are a plethora of intriguing viral vector-based techniques for treating genetic illnesses. There are various successful therapy options for several human disorders.
Title : Dengue transmission and Aedes vector dynamics before, during and after COVID-19 travel restrictions
Ranjan Ramasamy, IDFISH Technology and University of Jaffna, United States
Title : Viral RNA structures as regulators of gene expression and therapeutic targets
Silvi Rouskin, Harvard Medical School, United States
Title : Novel functions of IRF3 in viral infection and inflammation
Saurabh Chattopadhyay, The University of Toledo, United States
Title : Therapeutic intervention of Bunyavirus induced hemorrhagic fever and cardiopulmonary disease
Mohammad Mir, Western University of Health Sciences, United States
Title : Why and how we discover and study the biology of viruses of micro-organisms in Aotearoa New Zealand
Robin Mac Diarmid, University of Auckland, New Zealand
Title : Antiviral action of aqueous extracts of propolis from scaptotrigona aff. postica against zica, chikungunya, and mayaro virus
Zucatelli, Instituto Butantan, Brazil